Kodak to explore strategic alternatives for health business

May 8, 2006
To assist in this effort, Kodak has retained Goldman, Sachs & Co. as its adviser.

ROCHESTER, NY-- Eastman Kodak Company has announced that it is exploring strategic alternatives for its Health Group.

Kodak's Health Group, with 2005 revenue of $2.7 billion, is a worldwide leader in health imaging, including digital x-ray capture, medical printers, and X-ray film.

"Kodak has a history of innovation in this industry, through which we have built a business with significant market presence and intellectual property assets," said Antonio M. Perez, Kodak's Chairman and Chief Executive Officer.

"We have proven products and technology, a well-known and respected brand, worldwide distribution, a large, satisfied and loyal customer base, and employees with unrivaled experience in health imaging.

"Our stated corporate goal is to be among the top three in each of the businesses in which we compete," Perez said. "While the Health Group is enjoying strong organic growth in elements of its digital portfolio, such as digital capture solutions and healthcare information solutions, we have been observing for some time consolidation in this industry. Given our valuable assets and the changing market landscape, we feel that now is the time to investigate strategic alternatives."

To assist in this effort, Kodak has retained Goldman, Sachs & Co. as its adviser.